The Canadian government approved Botox (Botulinum toxin type A) for the treatment of ophthalmic disorders associated with muscle overactivity such as misalignment of the eyes and contractions of the eyelids. Since then, it has also received approval to relieve a variety of conditions involving hyperactive muscles - most recently, cerebral palsy in children
Comment Reply
The Canadian government approved Botox (Botulinum toxin type A) for the treatment of ophthalmic disorders associated with muscle overactivity such as misalignment of the eyes and contractions of the eyelids. Since then, it has also received approval to relieve a variety of conditions involving hyperactive muscles - most recently, cerebral palsy in children
April 29, 2009 - 7:16amThis Comment
Reply